| - GRCh37:
- Chr2:178096463
- GRCh38:
- Chr2:177231735
| NFE2L2 | I190V, I217V, I260V, I267V, I274V, I290V | Immunodeficiency, developmental delay, and hypohomocysteinemia | Uncertain significance (Jan 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:178098956
- GRCh38:
- Chr2:177234228
| NFE2L2 | L14P, L30P | Immunodeficiency, developmental delay, and hypohomocysteinemia, not provided | Conflicting interpretations of pathogenicity (Feb 2, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:178095986
- GRCh38:
- Chr2:177231258
| NFE2L2 | R376C, R449C, R419C, R349C, R433C, R426C | not provided, Immunodeficiency, developmental delay, and hypohomocysteinemia | Uncertain significance (May 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:178095707
- GRCh38:
- Chr2:177230979
| NFE2L2 | E469K, E512K, E526K, E542K, E519K, E442K | Immunodeficiency, developmental delay, and hypohomocysteinemia | Uncertain significance (Apr 19, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:178098954
- GRCh38:
- Chr2:177234226
| NFE2L2 | G31R, G15R | Immunodeficiency, developmental delay, and hypohomocysteinemia, Colorectal cancer | Pathogenic/Likely pathogenic (Aug 28, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr2:178098804
- GRCh38:
- Chr2:177234076
| NFE2L2 | G81S, G65S | Immunodeficiency, developmental delay, and hypohomocysteinemia | Pathogenic (Oct 30, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr2:178098806
- GRCh38:
- Chr2:177234078
| NFE2L2 | T80K, Q4K, T64K | not provided | Pathogenic (Apr 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:178098810
- GRCh38:
- Chr2:177234082
| NFE2L2 | E63K, E79K | Neoplasm of uterine cervix, Immunodeficiency, developmental delay, and hypohomocysteinemia, Hepatocellular carcinoma, Squamous cell lung carcinoma, Lung adenocarcinoma, Squamous cell carcinoma of the head and neck, Transitional cell carcinoma of the bladder | Pathogenic/Likely pathogenic (Aug 28, 2018) | no assertion criteria provided |